³ΙΘΛΏμΚΦ

header-logo
GettyImages-609179959-hero
headshot

Razelle Kurzrock, MD, FACP

Center Associate Director, Professor

view provider profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Medical Oncology

Languages

  • English

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine
  • FACP - Fellow of the American College of Physicians

Leadership Positions

  • Associate Director of Clinical Research, Cancer Center
  • Associate Director of Clinical Research, GSPMC

Publications

  • (Fujiwara Y, Kato S, Kurzrock R.) Hematol Oncol Clin North Am. 2026 Oct;40(5):685-704 PMID: 42686322 SCOPUS ID: 2-s2.0-105049040188 09/03/2026

  • (Seibt T, Hoeft K, Schaefer GJL, Wahida A, Kurzrock R, Conrad M, Kramann R.) Nat Rev Nephrol. 2026 Sep 10 PMID: 42722810 SCOPUS ID: 2-s2.0-105050331174 09/11/2026

  • (Nikanjam M, Pérez-Granado J, Gramling MW, Larvol B, Kurzrock R.) Clin Cancer Res. 2026 Sep 01;32(17):3721-3734 PMID: 42378036 PMCID: PMC13500217 SCOPUS ID: 2-s2.0-105049017548 06/30/2026

  • (Farahnak F, El-Deiry WS, Lussier YA, Kurzrock R, Magidi S, Bresson C, Enger SA, Liu J, Bar J, Warner JL, Meissner T, Rubin E, Rueter J, Gaddipati H, Kulkarni M, Chen Z, Limaye S, Elsey R, Rubenstein BM, Joshua AM, Al-Shamsi HO, Musallam KM, Wunder F, Raynaud J, Berchem G, Gantenbein M, Al Omari A, Dermime S, Abdel-Razeq H, Saintigny P, Cervantes A, Reddel RR, Aref AT, Martin-Liberal J, Lázaro C, Romera DC, Sekacheva M, Berger R, Pramesh CS, Berindan-Neagoe I, Girda E, Piris-Gimenez A, Farhangfar CJ, Salem ME, Dienstmann R, Salazar R, Frankel NZ, Batist Z, Quintana Y, Batist G.) JCO Glob Oncol. 2026 Aug;12(8):e2500720 PMID: 42594326 PMCID: PMC13532739 SCOPUS ID: 2-s2.0-105047314017 08/13/2026

  • (El-Deiry WS, Hernando-Calvo A, Dizon D, Magidi S, Bresson C, Cheng L, Liu J, Hu Z, Hattum C, Meissner T, Grisson R, Liu L, Oberoi A, Frankel NZ, Wunder F, Kurzrock R.) Oncotarget. 2026 Jul 21;17(1):341-352 PMID: 42478852 PMCID: PMC13637840 SCOPUS ID: 2-s2.0-105045823877 07/21/2026

  • (Dorbin D, Herrera J, Davidson R, Chandrashekar NK, Scheuber G, Jayakrishnan P, Rajesh C, Johnson G, Yuan J, Sochor M, Langenheim JF, Aldakkak M, Messerly C, Wittmann J, Szabo A, Azam Sayahpour F, Atallah NL, Peterson FC, Volkman BF, Ali M, Ke E, Evans DB, Tsai S, Lytle NK, Seo YD, Kurzrock R, Hobbs GA, Kamgar M, McFall T.) bioRxiv. 2026 Jul 10 PMID: 42465401 PMCID: PMC13371077 07/17/2026

  • (Khalid N, Kurzrock R, Kato S.) NPJ Precis Oncol. 2026 Jul 08 PMID: 42420363 07/09/2026

  • (Grahl J, Ferrusquia R, Mills M, Schneider R, Beachy A, Chen HZ, Kurzrock R.) J Immunother Precis Oncol. 2026 Jun;9(3):109-112 PMID: 42454255 PMCID: PMC13366830 07/15/2026

  • (Lemert P, Chen HZ, Shreenivas A, Eaves K, Kurzrock R.) JCO Oncol Adv. 2026 Apr;3(2) PMID: 42422224 PMCID: PMC13344466 07/09/2026

  • (Chae YK, Sun R, Patel SP, Giles F, Ohr JP, Worden FP, Suga JM, Naing A, Cohen EE, Wallace J, Kang HS, Fenton S, Chung LI, McLeod CM, Chen HX, Sharon E, Streicher H, Ryan CW, Othus M, Blanke CD, Kurzrock R.) Ther Adv Med Oncol. 2026;18:17588359261451739 PMID: 42499790 PMCID: PMC13396573 SCOPUS ID: 2-s2.0-105045765417 07/25/2026

  • (Thapa B, Nishizaki D, Miyashita H, Lee S, Nesline MK, Previs RA, Conroy JM, Jensen TJ, DePietro P, Pabla S, Kato S, Kurzrock R.) Ther Adv Med Oncol. 2026;18:17588359261456325 PMID: 42453651 PMCID: PMC13365659 SCOPUS ID: 2-s2.0-105044508814 07/15/2026

  • (Shreenivas A, Elliott A, Corbiere T, Chen HZ, George B, Kamgar M, Chakrabarti S, Desai A, Bracken-Clarke D, Xue E, Floudas CS, Thomas J, Xiu J, Sledge G, Antonarakis ES, Boumber Y, Kurzrock R.) ESMO Open. July 2026;11(7) SCOPUS ID: 2-s2.0-105041663052 07/01/2026

Publications of from the

© 2026 ³ΙΘΛΏμΚΦ.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The ³ΙΘΛΏμΚΦ (³ΙΘΛΏμΚΦ) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. ³ΙΘΛΏμΚΦ maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

³ΙΘΛΏμΚΦ's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the ³ΙΘΛΏμΚΦ community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.